Table 2.

Main features of active cancer

Site of active cancer (832 patients)	Active cancer n (%)
Lung, n (%)	165 (19.8)
Gastrointestinal, n (%)	175 (21.0)
Urogenital, n (%)	191 (23.0)
Hematological, n (%)	106 (12.7)
Brain, n (%)	35 (4.2)
Other, n (%)	142 (17.1)
Not known, n (%)	18 (2.2)
Metastatic (728 pts), n (%)	419 (57.6)
Ongoing chemotherapy (791 pts)a, n (%)	364 (46.0)
Ongoing radiotherapy (788 pts)a, n (%)	128 (16.2)

^aPercentages were evaluated on patients with data available reported in brackets for each variable